Quantcast

Latest TB Stories

2012-08-24 23:03:37

Global NGO's Program to Improve Health of Ukrainians Through TB Testing And Other Measures to Prevent Rapid Increase of the Disease in Ukraine - Fifth Largest TB Burden Country In the World. Millwood, VA (PRWEB) August 23, 2012 Project HOPE, a global health education and humanitarian assistance organization, has received $4.7 million from USAID to strengthen the tuberculosis (TB) infection control program in Ukraine. The five-year program will be implemented with Chemonics. The program...

2012-08-13 12:57:53

Scientists of the Antwerp Institute of Tropical Medicine have breathed new life into a forgotten technique and so succeeded in detecting resistant tuberculosis in circumstances where so far this was hardly feasible. Tuberculosis bacilli that have become resistant against our major antibiotics are a serious threat to world health. If we do not take efficient and fast action, 'multiresistant tuberculosis' may become a worldwide epidemic, wiping out all medical achievements of the last...

2012-07-24 11:05:59

Lancet paper finds novel drug regimen could be more effective than existing treatments; TB Alliance's trial to test drugs in combination saves years in research time A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the...

2012-07-24 10:10:48

In January, 2012, the U.S. Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease. The drug rifampin, used for treating TB, can lower levels of the HIV medicine efavirenz, so the FDA recommended that patients who weigh more than 50 kg (110 pounds) and who are taking both medications should get 30...

2012-06-28 20:18:49

Inhibiting immune response early on could speed treatment time, prevent relapse Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could – paradoxically – shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB Research. Shorter duration of drug therapy is key, researchers say, to increase treatment compliance for the growing global health...

Swab Technique Spots Tuberculosis In Non-human Primates
2012-06-25 10:16:35

TB infections, a serious threat to monkeys and apes, previously had been difficult to detect Tuberculosis can be a serious threat to monkeys and apes. A new technique for detecting the tuberculosis-causing bacteria could help in protecting the health of primate populations. The method can spot TB even among infected primates that show no outward sign of disease, but are still capable of spreading infection to others of their kind. Existing tests for TB in primates are difficult to...

2012-06-17 23:01:34

Immune Network Ltd. (IMMFF), announces the completion of a Phase II trial of a once-daily M. vaccae pill (V7) conducted by Immunitor in Ukraine. The imm02 study was aimed to seek whether oral formulation of inactivated whole cell mycobacteria can shorten TB treatment duration. Vancouver, Canada (PRWEB) June 17, 2012 The phase II, placebo-controlled trial, conducted by experts in the field of TB immunotherapy, was set to evaluate the efficacy of tableted, heat-killed Mycobacterium vaccae in...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.